Abstract
Co-delivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for synergistic cancer treatment
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of controlled release : official journal of the Controlled Release Society
Paper Title
Journal
Date
